Editorial: thiopurine/anti-TNF use during pregnancy-more encouraging safety data

被引:2
|
作者
Chowdhury, Reezwana [1 ]
Kane, Sunanda [2 ]
机构
[1] Johns Hopkins Univ, Div Gastroenterol & Hepatol, Baltimore, MD USA
[2] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
关键词
EXPOSURE; CHILDREN; OUTCOMES;
D O I
10.1111/apt.16017
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1409 / 1410
页数:2
相关论文
共 50 条
  • [1] Editorial: thiopurine/anti-TNF use during pregnancy-more encouraging safety data. Authors' reply
    Mertz Norgard, Bente
    Friedman, Sonia
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (08) : 1411 - 1411
  • [2] Commentary: safety of anti-TNF use in pregnancy
    Hart, Ailsa
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (01) : 205 - 206
  • [3] Safety of anti-TNF agents in pregnancy
    De Felice, Kara M.
    Kane, Sunanda
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 148 (03) : 661 - 667
  • [4] Safety of Immunomodulators and Anti-TNF Therapy in Pregnancy
    Khadija H. Chaudrey
    Sunanda V. Kane
    [J]. Current Treatment Options in Gastroenterology, 2015, 13 (1) : 77 - 89
  • [5] Safety of anti-TNF therapy in inflammatory bowel disease during pregnancy
    Khan, Nabeel
    Asim, Hamna
    Lichtenstein, Gary R.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2014, 13 (12) : 1699 - 1708
  • [6] Optimal anti-TNF stop week during pregnancy depends on anti-TNF type
    Kanis, S.
    de Lima, A.
    van der Woude, C.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S11 - S11
  • [7] OPTIMAL ANTI-TNF STOP WEEK DURING PREGNANCY DEPENDS ON ANTI-TNF TYPE
    Kanis, Shannon L.
    de Lima, Alison
    Van der Woude, Christien Janneke
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S85 - S85
  • [8] Validation of the Pharmacokinetic Model for Anti-TNFα Clearance in Infants Exposed to Anti-TNFα During Pregnancy
    Wieringa, Jantien W.
    Kruizinga, Matthijs D.
    Driessen, Gertjan J. A.
    van der Woude, C. Janneke
    Julsgaard, Mette
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 (04): : 506 - 515
  • [9] Safety of Anti-TNF Agents During Pregnancy and Breastfeeding in Women With Inflammatory Bowel Disease
    Gisbert, Javier P.
    Chaparro, Maria A.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (09): : 1426 - 1438
  • [10] Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety
    de Lima, A.
    Zelinkova, Z.
    van der Ent, C.
    Steegers, E. A. P.
    van der Woude, C. J.
    [J]. GUT, 2016, 65 (08) : 1261 - 1268